Pan Heng-Chih, Jenq Chang-Chyi, Lee Wei-Chen, Tsai Ming-Hung, Fan Pei-Chun, Chang Chih-Hsiang, Chang Ming-Yang, Tian Ya-Chung, Hung Cheng-Chieh, Fang Ji-Tseng, Yang Chih-Wei, Chen Yung-Chang
Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan.
Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan; Chang Gung University College of Medicine, Taoyuan, Taiwan.
PLoS One. 2014 Sep 12;9(9):e107138. doi: 10.1371/journal.pone.0107138. eCollection 2014.
Liver transplantation can prolong survival in patients with end-stage liver disease. We have proposed that the Sequential Organ Failure Assessment (SOFA) score calculated on post-transplant day 7 has a great discriminative power for predicting 1-year mortality after liver transplantation. The Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) score, a modified SOFA score, is a newly developed scoring system exclusively for patients with end-stage liver disease. This study was designed to compare the CLIF-SOFA score with other main scoring systems in outcome prediction for liver transplant patients.
We retrospectively reviewed medical records of 323 patients who had received liver transplants in a tertiary care university hospital from October 2002 to December 2010. Demographic parameters and clinical characteristic variables were recorded on the first day of admission before transplantation and on post-transplantation days 1, 3, 7, and 14.
The overall 1-year survival rate was 78.3% (253/323). Liver diseases were mostly attributed to hepatitis B virus infection (34%). The CLIF-SOFA score had better discriminatory power than the Child-Pugh points, Model for End-Stage Liver Disease (MELD) score, RIFLE (risk of renal dysfunction, injury to the kidney, failure of the kidney, loss of kidney function, and end-stage kidney disease) criteria, and SOFA score. The AUROC curves were highest for CLIF-SOFA score on post-liver transplant day 7 for predicting 1-year mortality. The cumulative survival rates differed significantly for patients with a CLIF-SOFA score ≤8 and those with a CLIF-SOFA score >8 on post-liver transplant day 7.
The CLIF-SOFA score can increase the prediction accuracy of prognosis after transplantation. Moreover, the CLIF-SOFA score on post-transplantation day 7 had the best discriminative power for predicting 1-year mortality after liver transplantation.
肝移植可延长终末期肝病患者的生存期。我们曾提出,移植后第7天计算的序贯器官衰竭评估(SOFA)评分对预测肝移植后1年死亡率具有很大的鉴别力。慢性肝衰竭-序贯器官衰竭评估(CLIF-SOFA)评分是一种改良的SOFA评分,是专门为终末期肝病患者新开发的评分系统。本研究旨在比较CLIF-SOFA评分与其他主要评分系统在肝移植患者预后预测中的作用。
我们回顾性分析了2002年10月至2010年12月在一所三级大学医院接受肝移植的323例患者的病历。记录移植前入院第一天以及移植后第1、3、7和14天的人口统计学参数和临床特征变量。
总体1年生存率为78.3%(253/323)。肝脏疾病大多归因于乙型肝炎病毒感染(34%)。CLIF-SOFA评分比Child-Pugh积分、终末期肝病模型(MELD)评分、RIFLE(肾功能障碍风险、肾损伤、肾衰竭、肾功能丧失和终末期肾病)标准以及SOFA评分具有更好的鉴别力。肝移植后第7天CLIF-SOFA评分预测1年死亡率的受试者工作特征曲线下面积(AUROC)曲线最高。肝移植后第7天CLIF-SOFA评分≤8的患者与CLIF-SOFA评分>8的患者累积生存率差异显著。
CLIF-SOFA评分可提高移植后预后的预测准确性。此外,移植后第7天的CLIF-SOFA评分对预测肝移植后1年死亡率具有最佳鉴别力。